Development of a Mosquito Repellent Formulation Based on Nanostructured Lipid Carriers.

ABSTRACT: Arboviral diseases are a threat to global public health systems, with recent data suggesting that around 40% of the world's population is at risk of contracting arboviruses. The use of mosquito repellents is an appropriate strategy to avoid humans coming into contact with vectors transmitting these viruses. However, the cost associated with daily applications of repellents can make their use unfeasible for the low-income populations that most need protection. Therefore, the development of effective formulations offers a way to expand access to this means of individual protection. Consequently, research efforts have focused on formulations with smaller quantities of active agents and sustained release technology, aiming to reduce re-applications, toxicity, and cost. The present study invest

SUBMITTER: Abrantes DC 

PROVIDER: S-EPMC8542870 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature